Volume 24, Number 1—January 2018
CME ACTIVITY - Synopsis
Zika Virus Testing and Outcomes during Pregnancy, Florida, USA, 2016
Table 4
Characteristic | No. (%) | |
---|---|---|
Delivery status | ||
Delivered | 53 (60.9) | |
In utero |
34 (39.1) |
|
Testing status | ||
Tested | 43 (81.1) | |
Not tested |
10 (18.9) |
|
Test result | ||
Positive | 2 (4.7) | |
Negative | 39 (90.7) | |
Pending |
2 (4.7) |
|
Follow-up | ||
Lost to follow-up | 21 (39.6) | |
Continued care |
32 (60.4) |
|
Head circumference at birth | ||
Abnormal | 5 (9.4) | |
Within normal limits |
48 (90.6) |
|
Audiology testing | ||
Abnormal | 1 (1.9) | |
Normal | 43 (81.1) | |
Not tested |
9 (17.0) |
|
Fundoscopic exam results | ||
Abnormal | 8 (13.2) | |
Normal | 9 (16.9) | |
Pending | 13 (24.5) | |
Not tested |
24 (45.3) |
|
Cranial magnetic resonance imaging results | ||
Abnormal | 2 (3.8) | |
Not tested |
51 (96.2) |
|
Cranial ultrasound at birth | ||
Abnormal | 9 (17.0) | |
Normal | 29 (54.7) | |
Not tested | 15 (28.3) |
1These authors contributed equally to this article.
Page created: December 18, 2017
Page updated: December 18, 2017
Page reviewed: December 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.